Concentrations of granulocyte colony-stimulating factor in human milk after in vitro simulations of digestion

Citation
Da. Calhoun et al., Concentrations of granulocyte colony-stimulating factor in human milk after in vitro simulations of digestion, PEDIAT RES, 46(6), 1999, pp. 767-771
Citations number
26
Categorie Soggetti
Pediatrics,"Medical Research General Topics
Journal title
PEDIATRIC RESEARCH
ISSN journal
00313998 → ACNP
Volume
46
Issue
6
Year of publication
1999
Pages
767 - 771
Database
ISI
SICI code
0031-3998(199912)46:6<767:COGCFI>2.0.ZU;2-7
Abstract
Human milk contains proteins that survive digestion in the neonatal gastroi ntestinal tract. Our group and others have reported that granulocyte colony -stimulating factor (G-CSF), a hematopoietic cytokine that influences neutr ophil proliferation and differentiation, is present in human milk. We also reported that specific receptors for G-CSF are expressed on the villous ent erocytes of neonates. However, the physiologic role of milk-borne G-CSF is not known. Thus, we sought to evaluate the capacity of human milk to protec t G-CSF against proteolytic degradation after exposure to gastric secretion s obtained from preterm (PT) and term (T) neonates at pH concentrations of 3.2, 5.8, and 7.4. Specifically, we examined degradation of 1) endogenous G -CSF in PT (n = 15) and T (n = 15) human milk; 2) recombinant human G-CSF ( rhG-CSF) added to a protein-free buffer (n = 10, 5 PT and 5 T); and 3) rhG- CSF added to human milk (n = 12, 6 PT and 6 T), various commercially prepar ed infant formulas tit = 15), and cow's milli (n = 5). Endogenous G-CSF and rhG-CSF added to human milk resisted degradation at 1 and 2 h. However, wh en rhG-CSF was added to commercial formulas, >95% was degraded at 1 and 2 h at each pH level. Similarly, approximately 60% of rhG-CSF added to cow's m ilk was degraded at 1 and 2 h. We conclude that I) endogenous G-CSF and rhG -CSF added to human milk are protected from degradation after exposure to g astric secretions at physiologic pH levels, 2) rhG-CSF added to infant form ulas is not protected from degradation, and 3) it is likely that the G-CSF present in human milk is biologically available to the neonate.